You are here: Home » Markets » Features
Business Standard

Dilip Shanghvi, the man behind India's best stock, faces his biggest test

Shares of Sun Pharma have hit a wall after surging for 20 years

Ari Altstedter 

When Dilip Shanghvi wants something, he has a track record of getting it. One executive, Srinivas Lanka, recalls the founder of Sun Pharmaceutical Industries calling more than 100 times over three years with a job offer two decades ago. Shanghvi was setting off on an acquisition-fuelled strategy to transform his small generic drugmaker into an industry powerhouse, and he wouldn't take no for an answer. In the end, Shanghvi won over Lanka, who agreed to leave his job at global pharma giant Novartis AG and sign on as executive director in charge of Sun's Indian business in 1996, ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Thu, October 13 2016. 22:46 IST